Skip to main content
. 2010 Oct 27;81(1):195–201. doi: 10.1016/j.ejrad.2010.09.040

Table 1.

Summary of clinical profiles and methods of confirmation by group (N = 183).

Variablesa Group 1 Group 2
(n = 84) 2a (n = 40) 2b (n = 27) 2c (n = 32) p-Valueb
Age 72.8 ± 5.6 72.1 ± 7.7 72.4 ± 5.7 72.4 ± 5.0 0.556
Gender, males (%) 60 (71.4) 18 (46.2) 18 (66.7) 20 (62.5) 0.046
Previous PTB 2 (2.4) 5 (12.5) 26 (96.3) 3 (9.4) <.001*
Cancer history 8 (9.5) 0 (0) 2 (7.4) 3 (9.4) 0.240
Anemia 41 (48.8) 6 (15.0) 3 (11.1) 4 (12.5) <.001*
DM 32 (38.1) 12 (30.0) 9(33.3) 4 (12.5) 0.062
Alcoholism 11 (13.1) 6 (15.0) 4 (14.8) 4 (12.5) 0.837
Steroid use 27 (32.1%) 14 (35.0) 9 (33.3) 5 (15.6) 0.570
Uremia 12 (14.3) 7 (17.5) 4 (14.8) 6 (18.8) 0.594
Albumin <3 17 (20.2) 9 (22.5) 3 (11.1) 4 (12.5) 0.475
Sputums–
Spontaneous 70 (83.3) 21 (52.5) 0 (0) 0 (0) <.001*
Bronchoscopy (TBLB/washing/brushing) 19 (22.6) 19 (47.5) 27 (100) 32 (100) <.001*
Lag time of TB smear (days) 7.49 ± 2.66 6.63 ± 3.33 9.26 ± 2.88 9.34 ± 2.73 0.101
Lag time of TB culture (days) 37.80 ± 7.49 45.60 ± 5.47 44.48 ± 2.01 39.44 ± 5.85 <.001*
Surgical intervention 1 (1.2) 0 (0) 0 (0) 5 (15.6) 0.221
Blood culture 0 (0) 0 (0) 0 (0) 21 (65.6) <.001*
Urine culture 0 (0) 0 (0) 0 (0) 3 (9.4) 0.251
Pleural effusion culture 0 (0) 0 (0) 0 (0) 4 (12.5) 0.126
Antigen of atypical pneumonia and bacteria 0 (0) 0 (0) 0 (0) 8 (8.1) 0.008*
Non-TB pathogen
 Bacteria 0 (0) 0 (0) 0 (0) 24 (22.2) <.001*
 Fungus 0 (0) 0 (0) 0 (0) 1 (1.0) 1.000
 Virus 0 (0) 0 (0) 0 (0) 1 (1.0) 1.000
 Mycoplasma 0 (0) 0 (0) 0 (0) 6 (6.1) 0.032*